Evidence map›Paper›PMID 30227831›Full record

ArticleBMC infectious diseases2018

Virological failure among adolescents on ART, Harare City, 2017- a case-control study.

Zvanaka Sithole, Elizabeth Mbizvo, Prosper Chonzi, More Mungati, Tsitsi Patience Juru, Gerald Shambira, Notion Tafara Gombe, Mufuta Tshimanga

Registry-linked trialAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05278559 (Can Undetectable), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05278559 unknown statusnot on this mapstarted 2022, after this paper: background citation

Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living the HIV in Africa

TypeobservationalSponsorCentre for Sexual Health and HIV/AIDS Research ZimbabweRan2022 to 2024Enrolled300ConditionsHIV/AIDS
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zvanaka SitholeMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Elizabeth MbizvoMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Prosper ChonziCity Health Directorate, Harare, Zimbabwe.
More MungatiElizabeth Glaser Pediatirc AIDS Foundation, Lesotho, Swaziland.
Tsitsi Patience JuruMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe. tjuru@zimfetp.net.ORCID http://orcid.org/0000-0002-3570-2331
Gerald ShambiraMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Notion Tafara GombeMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Mufuta TshimangaMPH Programme, Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZimbabwe is on track towards achieving viral suppression among adults (87%). However, adolescents have only achieved 44% by 2016. In Harare city, 57% of adolescents had attained viral suppression after 12 months on ART compared to 88% among adults. We determined factors associated with virological failure among adolescents (age 10-19 years) on antiretroviral therapy (ART) in Harare city.

methodsWe conducted a one to one unmatched case control study among 102 randomly recruited case: control pairs at the two main infectious disease hospitals in Harare. A case was any adolescent who presented with VL > 1000c/ml after at least 12 months on ART. A control was any adolescent who presented with VL < 1000c/ml after at least 12 months on ART. Interviewer administered questionnaires were used to collect data. Epi Info 7 was used to generate frequencies, means, proportions, ORs and p-values at 95% CI.

resultsWe interviewed 102 case-control pairs. Poor adherence to ART [aOR = 8.15, 95% CI (2.80-11.70)], taking alcohol [aOR = 8.46, 95% CI (3.22-22.22)] and non- disclosure of HIV status [aOR = 4.56, 95% CI (2.20-9.46)] were independent risk factors for virological failure. Always using a condom [aOR = 0.04, 95% CI (0.01-0.35)], being on second line treatment [aOR = 0.04, 95% CI (0.23-0.81)] and belonging to a support group [aOR = 0.41, 95% CI (0.21-0.80)] were protective.

conclusionPoor adherence, alcohol consumption and non-disclosure increased the odds of virological failure. Based on these findings support should focus on behavior change and strengthening of peer to peer projects to help address issues related to disclosure and adherence. Further operational research should aim to define other components of effective adherence support for adolescents with virological failure.

Indexed as

Patient ComplianceAdolescentAdultAlcohol DrinkingAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCase-Control StudiesChildFemaleHIV InfectionsHumansMaleRisk FactorsSexual BehaviorTreatment FailureViral LoadAnti-HIV AgentsAdolescentsCase controlHarare cityViral load suppression

Identifiers

PMID30227831
PMCPMC6145182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.